Company
Vir Biotechnology
Also known as Vir Biotechnology, Inc
- Business model
- B2B
- Legal name
- Vir Biotechnology, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond.
Funding snapshot
- Total raised
- $348MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $32.4M2020-05-06
Funding rounds
- Round, 2020
- $32.4M2020-05-06, SEC form D sold, 1 investor
- Round, 2020
- $250M2020-04-29, SEC form D sold, 1 investor
- Round, 2018
- $66M2018-06-14, SEC form D sold, 5 investors
Loading relationship preview